Disease/Infection News

RSS

Combating the fourth wave of COVID-19 in Ontario

Researchers from Canada recently attempted to project the number of COVID-19 cases and the demand for acute hospital resources for Fall 2021 in a mid-sized southwestern Ontario community. They sought to evaluate if current vaccine coverage and contact reduction levels are sufficient to mitigate a possible 4th wave driven by the Delta variant, or if stricter public health measures need to be reinstituted.

8 Sep 2021

Mu SARS-CoV-2 variant highly resistant to neutralization by convalescent and vaccinated sera

Researchers in Japan have warned that the Mu (B.1.621) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – appears to be highly resistant to neutralization by sera from convalescent or vaccinated individuals.

8 Sep 2021

New vaccinia-based COVID-19 vaccine candidate induces robust, durable immune responses

Researchers in Australia have developed a coronavirus disease 2019 (COVID-9) vaccine that induced robust and long-lived humoral and cellular immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in both young and aging mice.

8 Sep 2021

Early implementation of social distancing policies results in smaller death tolls, but larger second waves

Early social distancing results in smaller death tolls, but leads to larger second waves, according to research led by faculty at Binghamton University, State University of New York.

8 Sep 2021

Study: Nearly one in five patients with malignant pleural mesothelioma contracted COVID-19

Nearly one in five patients with malignant pleural mesothelioma (MPM) at a Barcelona hospital contracted COVID-19 during the pandemic.

8 Sep 2021

Study measures the impact of stigma and discrimination on positive COVID-19 diagnosis

Stigma and discrimination linked to a positive COVID-19 diagnosis are the subjects of research being conducted by a multidisciplinary University of Queensland team.

8 Sep 2021

New suggestions emphasize the importance of contingency level care during COVID-19 pandemic

The journal CHEST recently published an important update to the 2014 consensus statement by the Task Force for Mass Critical Care (TFMCC) on providing mass critical care utilizing research gained through experiencing the 2020 COVID-19 pandemic.

8 Sep 2021

Neuropsychiatric symptoms in children and adolescents with long COVID

In a recent study, researchers determine the presence of any neuropsychological symptoms after recovering from COVID-19 in children and adolescents.

8 Sep 2021

The role of nanobodies in capturing and containing SARS-CoV-2

Scientists have repurposed the Nb Ty1 for the detection and neutralization of SARS-CoV-2.

8 Sep 2021

Genetically predicted COVID-19 linked to blood clots, thrombophlebitis and circulatory diseases

Research led by Queen Mary University of London associates genetically determined COVID-19 susceptibility with increased blood clot events in leg and lungs, thrombophlebitis and circulatory diseases.

8 Sep 2021

Research reveals a new role for platelets in COVID-19 blood vessel damage

Abnormal crosstalk between blood platelets and cells lining blood vessels is one cause of deadly organ damage in patients with severe COVID-19, a new study finds.

8 Sep 2021

Immunity induced by Pfizer/BioNTech COVID-19 vaccine declines with time, Mayo Clinic study finds

In a study conducted at the Mayo Clinic, USA, scientists have investigated the long-term efficacy of the mRNA-based coronavirus disease 2019 (COVID-19) vaccine BNT162b2 (Pfizer/BioNTech) against symptomatic disease.

8 Sep 2021

German study finds lack of association between SARS-CoV-2 infection and neuroaxonal damage

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the virus that causes coronavirus disease 2019 (COVID-19) – is not associated with neuroaxonal damage, according to a new study from researchers in Germany.

8 Sep 2021

Study suggests hospitalized COVID-19 patients have elevated Alzheimer's-related biomarkers

Neurological symptoms have been widely reported in patients with COVID-19 and in those who have recovered from it. A new study led by Thomas Wisniewski of New York University Grossman School of Medicine, USA, finds that patients hospitalized with COVID-19 are more likely to have elevated biomarkers levels indicative of age-related neurodegeneration.

8 Sep 2021

People living with HIV have higher risk of sudden cardiac death, finds study

People living with human immunodeficiency virus (HIV) have a higher risk of sudden cardiac death than people who do not have HIV, especially if the virus is not well-controlled or if they have other heart disease risk factors.

8 Sep 2021

Seizures as a main manifestation of severe pediatric SARS-CoV-2 infection

A new study aimed to investigate the clinical, demographic, laboratory, neurophysiological, and imaging characteristics of children admitted to the ED with seizures and acute SARS-CoV-2 infection.

8 Sep 2021

Sepsis mortality risk linked to the degree of platelet reduction

Researchers have revealed that the degree of platelet reduction, rather than absolute platelet count, is linked to mortality risk in sepsis.

8 Sep 2021

Research highlights inequalities in England's COVID vaccine coverage

Researchers led by the epidemiologist Elise Tessier, of Public Health England, have been investigating the proportion of unvaccinated individuals against coronavirus disease 2019 (COVID-19) by age, sex, location, vaccine type, ethnicity and poverty level in the United Kingdom.

8 Sep 2021

Researchers say modified COVID-19 vaccine boosters should control pandemic

Researchers in Texas have provided evidence for the need to modify the currently used coronavirus disease 2019 (COVID-19) vaccines to match circulating variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

8 Sep 2021

Understanding platelets in COVID-19 may help identify diagnostic markers and treatments

Researchers in the United States and Japan have provided novel insights into the pathologic mechanisms underlying coronavirus disease 2019 (COVID-19) that may aid the identification of potential diagnostic biomarkers and treatment targets.

8 Sep 2021

Disease/Infection News

Combating the fourth wave of COVID-19 in Ontario

Mu SARS-CoV-2 variant highly resistant to neutralization by convalescent and vaccinated sera

New vaccinia-based COVID-19 vaccine candidate induces robust, durable immune responses

Early implementation of social distancing policies results in smaller death tolls, but larger second waves

Study: Nearly one in five patients with malignant pleural mesothelioma contracted COVID-19

Study measures the impact of stigma and discrimination on positive COVID-19 diagnosis

New suggestions emphasize the importance of contingency level care during COVID-19 pandemic

Neuropsychiatric symptoms in children and adolescents with long COVID

The role of nanobodies in capturing and containing SARS-CoV-2

Genetically predicted COVID-19 linked to blood clots, thrombophlebitis and circulatory diseases

Research reveals a new role for platelets in COVID-19 blood vessel damage

Immunity induced by Pfizer/BioNTech COVID-19 vaccine declines with time, Mayo Clinic study finds

German study finds lack of association between SARS-CoV-2 infection and neuroaxonal damage

Study suggests hospitalized COVID-19 patients have elevated Alzheimer's-related biomarkers

People living with HIV have higher risk of sudden cardiac death, finds study

Seizures as a main manifestation of severe pediatric SARS-CoV-2 infection

Sepsis mortality risk linked to the degree of platelet reduction

Research highlights inequalities in England's COVID vaccine coverage

Researchers say modified COVID-19 vaccine boosters should control pandemic

Understanding platelets in COVID-19 may help identify diagnostic markers and treatments

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News